Mitomics
The company has rededicated itself to a fully blood-based test pipeline, with its next assays focused on women's health, including endometriosis and ovarian, uterine, and cervical cancers.
In Brief This Week: Mitomics, Sterling Pathology National Laboratories; J. Craig Venter Institute, CLC Bio; LabCorp
NEW YORK (GenomeWeb News) – Mitomics said this week it has entered into a sales and marketing deal with Sterling Pathology National Laboratories covering Mitomics' Prostate Core Mitomic Test.
Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay
Premium
Akonni Biosystems this week announced the results of three preclinical studies in support of the efficacy of its TruDiagnosis molecular diagnostics platform and TruArray tests, and said that the platform is now ready for expanded, multi-site clin
CML HealthCare to Offer Mitomics Prostate Test in Canada
NEW YORK (GenomeWeb News) – CML HealthCare today said that it has licensed exclusive rights to offer Mitomics' prostate cancer test in Canada.
Mitomics Inks Sales and Marketing Deal with LabCorp
NEW YORK (GenomeWeb News) – Mitomics today announced a deal with Laboratory Corporation of America to offer Mitomics' molecular prostate cancer test.
Sep 17, 2012
Mitomics Realigns, Eliminates Eight Positions
Feb 14, 2012
Mitomics Inks US Marketing Deal for Prostate Test
May 19, 2011
Mitomics, QDx Ink Development, Marketing Pact
Mar 31, 2011
Jul 16, 2010
People In The News: Jul 16, 2010
Jul 15, 2010